SCHEDULE 13D/A: OPKO Health Insider Dr. Jane Hsiao's Stake Dips Below 5% Threshold Due to Increased Outstanding Shares
Schedule 13D Amendment
Dr. Jane Hsiao's beneficial ownership in OPKO Health, Inc. has decreased to 4.48% from above 5%, triggering a Schedule 13D amendment, primarily due to an increase in the Issuer's total outstanding common stock.
Summary
- Dr. Jane Hsiao, a significant beneficial owner of OPKO Health, Inc. (the "Issuer"), has filed Amendment No. 11 to her Schedule 13D.
- The amendment reports that Dr. Hsiao's beneficial ownership has fallen below the 5% threshold, specifically to approximately 4.48% of the Issuer's common stock.
- This change is attributed solely to an increase in the Issuer's number of outstanding shares of Common Stock, which reached 793,051,553 shares as of April 3, 2025.
- Dr. Hsiao beneficially owns a total of 35,677,284 shares of Common Stock.
- This total includes 27,999,880 shares held individually by Dr. Hsiao, 5,127,404 shares held by Hsu Gamma Investment, L.P. (controlled by Dr. Hsiao as general partner), and options to acquire 2,550,000 shares exercisable within 60 days.
- Hsu Gamma Investments, L.P. separately beneficially owns 5,127,404 shares, representing approximately 0.65% of the outstanding common stock.
- Neither Dr. Hsiao nor Hsu Gamma effected any transactions in the shares of Common Stock in the 60 days prior to the filing of this Amendment No. 11.
Sentiment
Score: 5
Explanation: The document is a factual regulatory filing reporting a change in beneficial ownership percentage due to an increase in outstanding shares. It does not contain positive or negative operational news, making its sentiment neutral. The dilution aspect is a factual consequence of increased shares, not a direct negative action by the reporting person.
Future Outlook
NA
Industry Context
This filing is a routine regulatory disclosure required when a beneficial owner's stake crosses certain thresholds. It does not provide insights into broader industry trends or competitive landscape, but rather reflects changes in a specific company's share structure and a significant shareholder's relative ownership.
Related Party Transactions
- Dr. Jane Hsiao controls Hsu Gamma Investment, L.P., and the shares held by Hsu Gamma are included in Dr. Hsiao's aggregate beneficial ownership.
Stakeholder Impact
- Shareholders: The increase in outstanding shares implies dilution for all existing shareholders, as the ownership percentage of a significant holder has decreased without a sale of shares by that holder.
- Dr. Jane Hsiao: Her beneficial ownership percentage has decreased below the 5% threshold, requiring this specific regulatory disclosure.
Key Dates
| Date | Description |
|---|---|
| 2008-02-14 | Original Schedule 13D filing date |
| 2008-08-21 | Amendment No. 1 to Schedule 13D filed |
| 2009-10-01 | Amendment No. 2 to Schedule 13D filed |
| 2013-03-22 | Amendment No. 3 to Schedule 13D filed |
| 2013-09-16 | Amendment No. 4 to Schedule 13D filed |
| 2015-12-18 | Amendment No. 5 to Schedule 13D filed |
| 2018-11-20 | Amendment No. 6 to Schedule 13D filed |
| 2019-11-01 | Amendment No. 7 to Schedule 13D filed |
| 2020-03-20 | Amendment No. 8 to Schedule 13D filed |
| 2022-08-19 | Amendment No. 9 to Schedule 13D filed |
| 2024-01-24 | Amendment No. 10 to Schedule 13D filed |
| 2025-04-02 | Date Dr. Hsiao ceased to beneficially own more than 5% of Common Stock |
| 2025-04-03 | Date of filing of Amendment No. 11 and reported outstanding shares count |
Keywords
OPKO Health, Schedule 13D, beneficial ownership, common stock, Jane Hsiao, Hsu Gamma Investment, SEC filing, shareholder stake, dilution
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.